Home›People›Timothy Sweeney
Timothy Sweeney

Timothy Sweeney

Co-founder and CEO of Inflammatix

ExecutiveDirector
Updated Nov 19, 2026·Latest SEC filing Nov 19, 2026·Suggest an edit

About Timothy Sweeney

Timothy Sweeney is co-founder and CEO of Inflammatix. The company develops rapid tests that read immune responses to help physicians diagnose acute infections and sepsis. He is a licensed physician and data scientist.

After completing an MD/PhD at Duke University, Sweeney trained in Stanford University's general surgery residency program. While training as a surgeon, he grew frustrated with existing infection diagnostic tools. During his residency research years, he completed a postdoctoral master's in biomedical informatics and worked with Purvesh Khatri. Their data methods became Inflammatix's core technology for diagnosing infections through immune responses. Sweeney is also an Inflammatix director.

Experience

This experience comes from official bios, from Timothy Sweeney's profile and from SEC filings. For roles taken from filings, the years are when the filings name Timothy Sweeney in the role, so the role may have started earlier or lasted longer.

Sepsis Alliance Current
Board Member
2026 – Present
Inflammatix, Inc. Current
Co-Founder and CEO, director
2020 – Present · Sunnyvale, CA
Inflammatix helps emergency teams identify infection type and illness severity from the body's immune response.
Stanford University Institute of Immunity, Transplantation and Infection
Research Associate
2015 – 2017
U.S. Department of Veterans Affairs
Surgical Hospitalist (part-time)
2013 – 2017
Stanford University School of Medicine
Resident, General Surgery
2011 – 2015

Key Colleagues at Startups

The people Timothy Sweeney works with at each company, as listed on that company's latest Form D.

Inflammatix, Inc. · Form D, Nov 19, 2026
FK
Florian Kainzinger
Founder, Think.Health Ventures and director
IC
Ingo Chakravarty
Operating Partner at Northpond Ventures and director
Steven Tablak
Steven Tablak
Former Chairman and CEO, GeneWeave
JR
Jonathan Romanowsky
Co-Founder and director
David Persing
David Persing
EVP/Chief Medical Officer, Cepheid and director

Sources

  1. SECInflammatix, Inc. Form D, filed Nov 19, 2026
  2. P1Inflammatix home page
  3. P4Inflammatix Nature Medicine publications release
  4. P7Inflammatix board appointment release